A. McLean

665 total citations
16 papers, 508 citations indexed

About

A. McLean is a scholar working on Transplantation, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, A. McLean has authored 16 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 5 papers in Epidemiology and 5 papers in Psychiatry and Mental health. Recurrent topics in A. McLean's work include Renal Transplantation Outcomes and Treatments (13 papers), Neurological Complications and Syndromes (5 papers) and Cytomegalovirus and herpesvirus research (4 papers). A. McLean is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Neurological Complications and Syndromes (5 papers) and Cytomegalovirus and herpesvirus research (4 papers). A. McLean collaborates with scholars based in United Kingdom, Australia and France. A. McLean's co-authors include David Taube, Andrew Palmer, Joel Owen, Jack Galliford, Paul Brookes, Michelle Willicombe, Vassilios Papalois, Candice Roufosse, Eva Santos‐Nunez and Tom Cairns and has published in prestigious journals such as Scientific Reports, Transplantation and American Journal of Transplantation.

In The Last Decade

A. McLean

16 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. McLean United Kingdom 10 318 189 139 102 86 16 508
Attapong Vongwiwatana Thailand 9 303 1.0× 211 1.1× 197 1.4× 102 1.0× 100 1.2× 35 665
Fernando Cosio United States 6 523 1.6× 188 1.0× 290 2.1× 70 0.7× 98 1.1× 14 646
Marcelina Żabińska Poland 13 296 0.9× 125 0.7× 228 1.6× 59 0.6× 200 2.3× 40 569
V.R. Peddi United States 13 363 1.1× 70 0.4× 208 1.5× 40 0.4× 54 0.6× 33 546
Isabel Roberti United States 10 153 0.5× 98 0.5× 116 0.8× 61 0.6× 44 0.5× 22 306
Marta Myszka Poland 11 285 0.9× 108 0.6× 233 1.7× 42 0.4× 165 1.9× 24 479
Michael Duerr Germany 12 293 0.9× 59 0.3× 147 1.1× 80 0.8× 56 0.7× 32 470
Andrew Bentall United States 14 491 1.5× 189 1.0× 285 2.1× 76 0.7× 184 2.1× 51 693
Janka Slatinská Czechia 10 234 0.7× 90 0.5× 105 0.8× 30 0.3× 137 1.6× 38 369
Delphine Morel France 11 97 0.3× 114 0.6× 97 0.7× 57 0.6× 75 0.9× 18 368

Countries citing papers authored by A. McLean

Since Specialization
Citations

This map shows the geographic impact of A. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. McLean more than expected).

Fields of papers citing papers by A. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. McLean. The network helps show where A. McLean may publish in the future.

Co-authorship network of co-authors of A. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of A. McLean. A scholar is included among the top collaborators of A. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. McLean. A. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Toulza, Frédéric, Kathy Dominy, Terry Cook, et al.. (2020). Technical considerations when designing a gene expression panel for renal transplant diagnosis. Scientific Reports. 10(1). 17909–17909. 9 indexed citations
2.
Willicombe, Michelle, Candice Roufosse, Eva Santos‐Nunez, et al.. (2014). Significance of HLA IgM and IgM Donor Specific Antibodies in Renal Transplantation.. Transplantation. 98. 435–435. 3 indexed citations
3.
Willicombe, Michelle, Bynvant Sandhu, Paul Brookes, et al.. (2013). Postanastomotic Transplant Renal Artery Stenosis: Association With De Novo Class II Donor-Specific Antibodies. American Journal of Transplantation. 14(1). 133–143. 49 indexed citations
4.
Armstrong‐James, Darius, Ian Teo, Susanne Herbst, et al.. (2012). Renal Allograft Recipients Fail to Increase Interferon-γ During Invasive Fungal Diseases. American Journal of Transplantation. 12(12). 3437–3440. 14 indexed citations
5.
Kort, Hanneke de, Michelle Willicombe, Paul Brookes, et al.. (2012). Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific Antibodies. American Journal of Transplantation. 13(2). 485–492. 85 indexed citations
6.
Willicombe, Michelle, Paul Brookes, Eva Santos‐Nunez, et al.. (2011). Outcome of Patients with Preformed Donor-Specific Antibodies Following Alemtuzumab Induction and Tacrolimus Monotherapy. American Journal of Transplantation. 11(3). 470–477. 42 indexed citations
7.
Vernon, Katherine A., Daniel P. Gale, Elena Goicoechea de Jorge, et al.. (2010). Recurrence of Complement Factor H-Related Protein 5 Nephropathy in a Renal Transplant. American Journal of Transplantation. 11(1). 152–155. 33 indexed citations
8.
Borrows, Richard, Marina Loucaidou, Thomas Cairns, et al.. (2005). Steroid Sparing in Renal Transplantation With Tacrolimus and Mycophenolate Mofetil: Three-Year Results. Transplantation Proceedings. 37(4). 1792–1794. 6 indexed citations
9.
Loucaidou, Marina, Richard Borrows, Thomas Cairns, et al.. (2005). Late Steroid Withdrawal for Renal Transplant Recipients on Tacrolimus and MMF Is Safe. Transplantation Proceedings. 37(4). 1795–1796. 9 indexed citations
10.
Borrows, Richard, Gary Chusney, Marina Loucaidou, et al.. (2005). Mycophenolic Acid 12-h Trough Level Monitoring in Renal Transplantation: Association with Acute Rejection and Toxicity. American Journal of Transplantation. 6(1). 121–128. 115 indexed citations
11.
Duncan, Neill, Ajay Dhaygude, Joel Owen, et al.. (2004). Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrology Dialysis Transplantation. 19(12). 3062–3067. 59 indexed citations
12.
Loucaidou, Marina, A. McLean, Thomas Cairns, et al.. (2003). Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. Transplantation. 76(7). 1120–1122. 5 indexed citations
13.
Cohen, S B, P. Sweny, J. Alejandro Madrigal, et al.. (2001). FK506 and CsA differ in their effect on intracellular cytokine expression following kidney transplantation. Transplantation Proceedings. 33(1-2). 1046–1047. 4 indexed citations
14.
Kingdon, Edward, A. McLean, Erasmia Psimenou, et al.. (2001). The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus. 10(9). 606–611. 68 indexed citations
15.
McLean, A., O. N. Fernando, Z. Varghese, & P Sweny. (1997). Conversion of stable renal allografts from CyA to azathioprine: A 5-year follow-up. Transplantation Proceedings. 29(1-2). 285–285. 1 indexed citations
16.
Pfitzner, J., et al.. (1988). Hypoxaemia following Sustained Low-Volume Venous Air Embolism in Sheep. Anaesthesia and Intensive Care. 16(2). 164–170. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Attapong Vongwiwatana Breakdown of academic impact, for papers by Fernando Cosio Breakdown of academic impact, for papers by Marcelina Żabińska Breakdown of academic impact, for papers by V.R. Peddi Breakdown of academic impact, for papers by Isabel Roberti Breakdown of academic impact, for papers by Marta Myszka Breakdown of academic impact, for papers by Michael Duerr Breakdown of academic impact, for papers by Andrew Bentall Breakdown of academic impact, for papers by Janka Slatinská Breakdown of academic impact, for papers by Delphine Morel
Rankless by CCL
2026